From: SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma
Variables | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
HR | 95Â % CI | P value | HR | 95Â % CI | P value | |||
SLC39A6 expression | 2.780 | 1.230 | 6.281 | 0.014 | 2.536 | 1.079 | 5.962 | 0.033 |
Gender (female) | 1.400 | 0.706 | 2.773 | 0.335 | 1.522 | 0.734 | 3.157 | 0.259 |
Age (>60Â years) | 0.843 | 0.443 | 1.602 | 0.601 | 0.914 | 0.466 | 1.79 | 0.793 |
Differentiation (moderate) | 0.798 | 0.314 | 2.027 | 0.636 | 0.963 | 0.370 | 2.509 | 0.939 |
Differentiation (poor) | 0.886 | 0.393 | 1.998 | 0.770 | 0.879 | 0.373 | 2.072 | 0.768 |
Lymph node metastasis (yes) | 2.315 | 1.226 | 4.371 | 0.010 | 2.129 | 0.611 | 7.412 | 0.235 |
TNM stage (IIIÂ +Â IV) | 2.146 | 1.134 | 4.063 | 0.019 | 1.034 | 0.303 | 3.523 | 0.958 |